Submitted by Anonymous (not verified) on 26 March 2025 - 16:20
Human medicines European public assessment report (EPAR): Cosentyx, secukinumab, Date of authorisation: 14/01/2015, Revision: 40, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Cosentyx, secukinumab, Date of authorisation: 14/01/2015, Revision: 40, Status: Authorised